These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7190156)

  • 1. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.
    Ishii H; Hayashi M; Niwaguchi T; Nakahara Y
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds].
    Niwaguchi T; Nakahara Y; Ishii H
    Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes.
    Inoue T; Niwaguchi T; Murata T
    Xenobiotica; 1980 May; 10(5):343-8. PubMed ID: 7415216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of structural analogs of LSD].
    Mravec D; Kalamár J; Proksa B; Horák F
    Cesk Farm; 1975 Apr; 24(3):110-5. PubMed ID: 1157105
    [No Abstract]   [Full Text] [Related]  

  • 7. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of d-lysergic acid diethylamide and related compounds on melanophores].
    BERDE B; CERLETTI A
    Helv Physiol Pharmacol Acta; 1956; 14(3):325-33. PubMed ID: 13405353
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the pharmacology of D-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):114-30. PubMed ID: 13545891
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding and circular dichroism studies on interactions of lysergic acid diethylamide with deoxyribonucleic acid.
    Bush CA; Pesce A; Gaizutis M; Nair V
    Mol Pharmacol; 1972 Jan; 8(1):104-9. PubMed ID: 5061517
    [No Abstract]   [Full Text] [Related]  

  • 13. Department of Microbiology, University of Illinois, Urbana, Illinois 61801.
    Voss EW; Cobb NE
    J Reticuloendothel Soc; 1975 Jan; 17(1):30-7. PubMed ID: 1167593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the problem of schizophrenia. IV. Distribution of C-14-radioactive lysergic acid diethylamide (C-14-LSD 25) in the animal organism].
    ARNOLD OH; HOFMANN G; LEUPOLD-LOWENTHAL H
    Wien Z Nervenheilkd Grenzgeb; 1958; 15(1-4):15-27. PubMed ID: 13604283
    [No Abstract]   [Full Text] [Related]  

  • 15. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysergic acid diethylamide. Photoelectron ionization potentials as indices of behavioral activity.
    Domelsmith LN; Munchausen LL; Houk KN
    J Med Chem; 1977 Oct; 20(10):1346-8. PubMed ID: 903923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on lysergic acid diethylamide and related compounds. 3. Improvement of amidation of lysergic acid (author's transl)].
    Nakahara Y; Niwaguchi T
    Yakugaku Zasshi; 1974 Mar; 94(3):407-12. PubMed ID: 4859118
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationships between chemical structure and psychoses with the use of psychotoxic substances; comparative pharmacopsychiatric analysis: a new research method.
    SOLMS H
    J Clin Exp Psychopathol; 1956; 17(4):429-33. PubMed ID: 13406032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research on the problem of schizophrenia using radiocarbon-labeled lysergic acid diethylamide & succinic acid].
    ARNOLD OH; HOFMANN G; LEUPOLDLOWENTHAL H
    Strahlentherapie; 1958; 107(Sonderbd. 38):59-65; discussion 66-7. PubMed ID: 13603137
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of lysergic acid diethylamide.
    BOYD ES
    Arch Int Pharmacodyn Ther; 1959 Jul; 120():292-311. PubMed ID: 13803540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.